Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BioRegenx
AddedFeb 15, 2024
UpdatedJun 18, 2026
BioRegenx

BioRegenx

Seed

US-based Bioregenx LLC. manufactures and sells healthcare and surgical supplies.

HQ
Chattanooga, TN, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

BioRegenx, Inc., headquartered in the United States, was founded with the mission to redefine health intelligence through innovative technologies. The company specializes in developing intellectual property (IP) and engages in regenerative biotherapeutics, anti-aging solutions, and artificial intelligence (AI) for healthcare. BioRegenx also focuses on bioinformatics for public and private transportation. Their primary market includes healthcare providers and institutions seeking advanced, non-invasive medical solutions.

Notable figures affiliated with BioRegenx include key industry experts and seasoned professionals in biotechnology and AI. The company has secured investments from prominent venture capitalists in the healthcare and tech sectors. BioRegenx's achievements include several patented technologies that have significantly impacted the fields of regenerative medicine and AI-driven healthcare solutions. Their innovations have contributed to advancements in non-invasive medical treatments, enhancing patient care and operational efficiency in healthcare systems.

BioRegenx - Similar Companies

InGeneron logo

InGeneron

ingeneron.com

AgeX Therapeutics logo

AgeX Therapeutics

Regenemed logo

Regenemed

regenemed.com

Juvent - Regenerative Technologies logo

Juvent - Regenerative Technologies

juvent.com

Bioregency logo

Bioregency

Bioincept logo

Bioincept

bioincept.com

America Great Health logo

America Great Health

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

CuraSeal logo

CuraSeal

Novoron Bioscience logo

Novoron Bioscience

novoron.com

Facegenics logo

Facegenics

facegenics.com

Ventrinova logo

Ventrinova

Rejuvenate Bio logo

Rejuvenate Bio

rejuvenatebio.com

Juvenescence logo

Juvenescence

juvlabs.com

Regenerative Bio logo

Regenerative Bio

regen-bio.us

BioRegenx - Quick Facts

Who are BioRegenx's competitors?

Companies similar to BioRegenx include InGeneron, AgeX Therapeutics, Regenemed and Juvent - Regenerative Technologies.

When was BioRegenx founded?

BioRegenx was founded in 2021.

Where is BioRegenx's headquarters located?

BioRegenx's headquarters is located in Chattanooga, TN, US.

When was BioRegenx's last funding round?

BioRegenx's most recent funding round was for $183k (USD) in April 2023.

How much has BioRegenx raised to-date?

As of Apr 4, 2023, BioRegenx has raised a total of $183k (USD).

How many employees does BioRegenx have?

BioRegenx has 30 employees as of Feb 5, 2024.

BioRegenx - Classification

Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Healthcare
Tags
  • Healthtech
Unique IDs
  • ein: 462836541
  • secCik: 0001593184
  • ticker: BRGX
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified